Qualigen Therapeutics Correlations

QLGN Stock

USD 3.41 0.07 2.10%

The current 90-days correlation between Qualigen Therapeutics and ZyVersa Therapeutics is 0.26 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Qualigen Therapeutics Correlation With Market

Average diversification

The correlation between Qualigen Therapeutics and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.

Moving together with Qualigen Stock

0.62	JNJ	Johnson Johnson	Pair Corr
0.68	MRK	Merck Company Earnings Call This Week	Pair Corr
0.66	INZY	Inozyme Pharma	Pair Corr
0.67	LPTX	Leap Therapeutics	Pair Corr
0.65	MREO	Mereo BioPharma Group	Pair Corr
0.7	NKTX	Nkarta Inc	Pair Corr
0.68	PDSB	PDS Biotechnology Corp	Pair Corr
0.61	ABBV	AbbVie Inc Earnings Call Today	Pair Corr
0.63	ABOS	Acumen Pharmaceuticals	Pair Corr
0.61	ADAP	Adaptimmune Therapeutics	Pair Corr
0.75	ACET	Adicet Bio	Pair Corr

Moving against Qualigen Stock

0.54	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.42	GILD	Gilead Sciences Earnings Call This Week	Pair Corr
0.4	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.46	BPMC	Blueprint Medicines Corp Sell-off Trend	Pair Corr
0.69	FNMFO	Federal National Mortgage	Pair Corr
0.6	ITCL	Banco Ita Chile	Pair Corr
0.52	AVAL	Grupo Aval	Pair Corr
0.52	TGNA	Tegna Inc	Pair Corr
0.51	CIB	Bancolombia SA ADR	Pair Corr
0.5	MNPR	Monopar Therapeutics	Pair Corr
0.49	DNOW	Now Inc	Pair Corr

Related Correlations Analysis

	ZVSA	IMMX	PHIO	ATNF	NAVB	TCON	ARDS	ENTX	ANEB
ZVSA		-0.57	0.3	0.64	0.85	0.77	-0.02	-0.07	0.69	ZVSA
IMMX	-0.57		-0.22	-0.62	-0.72	-0.54	0.32	0.58	-0.43	IMMX
PHIO	0.3	-0.22		0.26	0.33	0.29	-0.23	-0.19	0.22	PHIO
ATNF	0.64	-0.62	0.26		0.88	0.87	-0.37	-0.61	0.59	ATNF
NAVB	0.85	-0.72	0.33	0.88		0.88	-0.3	-0.43	0.73	NAVB
TCON	0.77	-0.54	0.29	0.87	0.88		-0.15	-0.36	0.6	TCON
ARDS	-0.02	0.32	-0.23	-0.37	-0.3	-0.15		0.64	-0.15	ARDS
ENTX	-0.07	0.58	-0.19	-0.61	-0.43	-0.36	0.64		-0.08	ENTX
ANEB	0.69	-0.43	0.22	0.59	0.73	0.6	-0.15	-0.08		ANEB
	ZVSA	IMMX	PHIO	ATNF	NAVB	TCON	ARDS	ENTX	ANEB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NAVB	+ 0.88	ATNF
TCON	+ 0.88	NAVB
TCON	+ 0.87	ATNF
NAVB	+ 0.85	ZVSA
TCON	+ 0.77	ZVSA
ANEB	+ 0.73	NAVB

High negative correlations

NAVB	- 0.72	IMMX
ATNF	- 0.62	IMMX
ENTX	- 0.61	ATNF
IMMX	- 0.57	ZVSA
TCON	- 0.54	IMMX
ENTX	- 0.43	NAVB

Risk-Adjusted Indicators

There is a big difference between Qualigen Stock performing well and Qualigen Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Qualigen Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	5.45	(0.48)	0.00	(0.06)	0.00	0.00	13.76	(8.06)	78.93
IMMX	4.46	0.48	0.07	9.93	4.75	(5.24)	9.38	(8.19)	33.17
PHIO	11.72	2.17	0.21	0.67	10.35	(17.83)	12.33	(11.53)	336.29
ATNF	5.11	(1.20)	0.00	(1.77)	0.00	0.00	9.79	(9.97)	79.11
NAVB	6.04	(1.01)	0.00	1.07	0.00	0.00	12.50	(12.50)	40.40
TCON	6.84	(1.64)	0.00	0.79	0.00	0.00	19.59	(17.77)	52.05
ARDS	7.73	1.33	0.11	(0.89)	7.66	(12.31)	12.50	(12.50)	140.53
ENTX	3.30	0.51	0.13	(0.85)	2.56	(4.83)	9.38	(4.76)	27.10
ANEB	4.42	(0.13)	0.00	(0.04)	0.00	0.00	7.64	(10.43)	40.03

Qualigen Therapeutics Corporate Management

Christopher Lotz	VP Secretary	Profile
MD MBA	Senior Officer	Profile
Amy Broidrick	Chief Pres	Profile
Wajdi AbdulAhad	VP Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC